- Report
- May 2025
- 350 Pages
Global
From €3527EUR$3,995USD£3,061GBP
- Report
- May 2025
- 650 Pages
Global
From €3527EUR$3,995USD£3,061GBP
- Report
- September 2025
- 681 Pages
Global
From €6176EUR$6,995USD£5,360GBP
- Report
- March 2025
- 585 Pages
Global
From €6176EUR$6,995USD£5,360GBP
- Report
- June 2025
- 463 Pages
Global
From €5188EUR$6,082USD£4,350GBP
- Report
- September 2024
- 106 Pages
Global
From €4856EUR$5,500USD£4,214GBP
- Report
- July 2025
- 150 Pages
Global
From €5254EUR$5,950USD£4,559GBP
- Report
- March 2025
- 180 Pages
Global
From €5254EUR$5,950USD£4,559GBP
- Report
- April 2025
- 200 Pages
Global
From €3965EUR$4,490USD£3,440GBP
- Report
- January 2025
- 175 Pages
Global
From €3965EUR$4,490USD£3,440GBP
- Report
- August 2025
- 180 Pages
Global
From €3130EUR$3,545USD£2,716GBP
€3478EUR$3,939USD£3,018GBP
- Report
- August 2025
- 186 Pages
Global
From €3130EUR$3,545USD£2,716GBP
€3478EUR$3,939USD£3,018GBP
- Report
- August 2025
- 182 Pages
Global
From €3130EUR$3,545USD£2,716GBP
€3478EUR$3,939USD£3,018GBP
- Report
- August 2025
- 192 Pages
Global
From €3130EUR$3,545USD£2,716GBP
€3478EUR$3,939USD£3,018GBP
- Report
- August 2025
- 191 Pages
Global
From €3130EUR$3,545USD£2,716GBP
€3478EUR$3,939USD£3,018GBP
- Report
- August 2025
- 181 Pages
Global
From €3130EUR$3,545USD£2,716GBP
€3478EUR$3,939USD£3,018GBP
- Report
- August 2025
- 180 Pages
Global
From €3130EUR$3,545USD£2,716GBP
€3478EUR$3,939USD£3,018GBP
- Report
- August 2025
- 188 Pages
Global
From €3130EUR$3,545USD£2,716GBP
€3478EUR$3,939USD£3,018GBP
- Report
- April 2025
- 175 Pages
Global
From €3965EUR$4,490USD£3,440GBP
- Report
- March 2025
- 200 Pages
Global
From €3965EUR$4,490USD£3,440GBP

The Genomic Medicine market is a rapidly growing sector of the genomics industry. It focuses on the development and application of genomic technologies to improve healthcare outcomes. This includes the use of genomic sequencing to diagnose and treat diseases, as well as the development of personalized treatments based on a patient's genetic profile. Genomic Medicine also involves the use of bioinformatics to analyze and interpret genomic data, and the development of new technologies to enable the use of genomic data in clinical practice.
The Genomic Medicine market is driven by the increasing availability of genomic data, advances in sequencing technologies, and the growing demand for personalized healthcare. It is expected to continue to grow in the coming years, as more healthcare providers adopt genomic technologies and the use of genomic data becomes more widespread.
Some companies in the Genomic Medicine market include Illumina, Thermo Fisher Scientific, BGI, and Pacific Biosciences. Show Less Read more